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OBJECTIVES: To evaluate the effect of transcutaneous tibial nerve stimulation (TTNS) and transcutaneous
parasacral stimulation on the treatment of overactive bladder (OAB) in elderly people and to compare the final
results between groups.
METHODS: Fifty female volunteers, mean age 68.62 (±5.9) years, were randomly allocated into two groups:
those receiving TTNS (G1, N=25) and those receiving transcutaneous parasacral stimulation (G2, N=25). The
primary outcome was the International Consultation on Incontinence Questionnaire (ICIQ-OAB) score, and
secondary outcomes were the International Consultation on Incontinence Questionnaire – short form (ICIQ-SF)
score and 3-day bladder diary measurements. Volunteers were assessed before and after the treatment. Clinical
Trials (ReBeC): RBR-9Q7J7Y.
RESULTS: Both groups’ symptoms improved as measured by the ICIQ-OAB (G1 =o0.001; G2 =o0.001) and ICIQ-
SF (G1 = o0.001; G2 = o0.001). In the 3-day bladder diary assessments after treatment, G1 showed a reduced
number of nocturia (po0.001), urgency (po0.001) and urge urinary incontinence episodes (po0.001), whereas
G2 showed only a reduced number of nocturia episodes (po0.001). No difference between groups was found.
CONCLUSION: Both of the proposed treatments were effective in the improvement of OAB symptoms, but TTNS
showed a reduction in a greater number of symptoms as measured by the 3-day bladder diary. No differences
were found between groups.
KEYWORDS: Overactive Urinary Bladder; Aged; Transcutaneous Electric Nerve Stimulation; Lower Urinary Tract
Symptoms.
’ INTRODUCTION
Overactive bladder (OAB) syndrome is defined as the
urgency to void, followed or not by urge urinary incontinence,
and it can be associated with symptoms such as daytime
micturition frequency and nocturia; the lack of urinary tract
infection or other pathology is mandatory for a conclusive
diagnosis (1). This condition has an important negative impact
on the patient’s quality of life, making the treatment relevant
(2). The prevalence of OAB varies by approximately 5 to 50%
(3), and symptoms are more likely to happen in elderly people
(4). Although OAB is idiopathic, changes induced by aging
such as estrogen deprivation (which leads to alterations in
bladder function), neurological changes (which lead to
changes in bladder sensation, making urgency more percep-
tive), and anatomic changes (which decrease bladder capacity,
detrusor contractility and flow rates) predispose patients to
OAB; for this reason, approximately 45% of women aged 65 or
more present with the syndrome (5).
The first-line treatment recommended by the International
Continence Society (ICS) includes non-invasive methods such
as medication, bladder training and pelvic floor muscle
training (6). Electrostimulation is a modality of conservative
treatment in which the therapeutic mechanism consists of
balancing the excitatory and inhibitory impulses that control
the bladder; it can be applied in different ways as parasacrally
(7), intravaginally/intranally (8) and in the tibial nerve (2).
Tibial nerve stimulation shows encouraging results in the
treatment of OAB (2), but, as there is still a lack of published
studies of this treatment, its level of recommendation is stillDOI: 10.6061/clinics/2020/e1477
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confused, and some authors recommend its use as second-
line therapy (5) and others third-line therapy (9). The tibial
nerve can be stimulated in a percutaneous way, where a
needle is positioned directly in the nerve, or in a transcuta-
neous way, where surface electrodes are positioned in the
region of the innervations of the tibial nerve; the latter is used
more frequently by physiotherapists because it is a non-
invasive method. A recent study showed that both of the
described methods have the same results in the treatment
of OAB (3).
Sacral stimulation is another way to balance bladder
impulses, but this electrostimulation modality has been
tested only in children (10) or with implantable electro-
des (9). No published data are available on parasacral
transcutaneous electrostimulation in the treatment of OAB in
adults.
As the particularities of the elderly population must be
taken into account in the prognosis of a treatment plan, as
tibial nerve stimulation in the treatment of OAB is still scarce
in the literature, and as sacral stimulation, which is effective
in modulating nervous control of the bladder, has never
been tested in the OAB elderly population, the aims of this
study are to assess the results of transcutaneous tibial nerve
stimulation and parasacral electrostimulation in the treat-
ment of OAB in elderly women and to compare the final
results between groups in an attempt to determine whether
one modality presents better results than the other in elderly
women.
’ METHODS
A randomized controlled trial was conducted by the
Program of Micturition Dysfunction at a health center in
Brasília, Brazil, from August 2017 to October 2018. The study
was approved by the Research Ethics Committee of School
of Medicine of the University of Brasília (CAEE-55919916.
9.0000.5558- December 1, 2016) in accordance with the
Declaration of the World Medical Association and Brazilian
Registry of Clinical Trials (REBEC), protocol number RBR-
9Q7J7Y. Consort statements were used. All patients signed
the informed consent form before the beginning of the
study.
Participants were eligible for inclusion if they were
between 60 and 80 years old and had received a clinical
diagnosis of OAB, defined by the presence of urgency
followed or not by urge urinary incontinence, nocturia and
an increased frequency of daytime urination.
The exclusion criteria were patients with positive urinalysis
and urine culture; a history of irradiation and/or hormonal
therapy in the last six months; the presence of neurological
diseases (multiple sclerosis, Alzheimer’s disease, stroke and
Parkinson’s disease); the use of anticholinergic drugs, calcium
antagonists, b-antagonists, and dopamine antagonists; the pre-
sence of pelvic organ prolapse (POP), as measured by a score
greater than III by the POP-Q system; and the inability to
answer the questionnaires properly. Clinical and sociodemo-
graphic variables such as age, BMI, parity and the number of
vaginal deliveries were registered.
Group randomization was performed using a computer
program for online randomization (http://www.random.
org) by a blind, block-based assessor. Patients were divided
into two groups: those receiving transcutaneous tibial nerve
stimulation (TTNS; G1) and those receiving transcutaneous
parasacral stimulation (G2).
Main outcome measures
The primary outcome was the score on the International
Consultation on Incontinence Questionnaire (ICIQ-OAB) (11).
Secondary outcomes were the International Consultation on
Incontinence Questionnaire – short form (ICIQ-SF) (12) score
and 3-day bladder diary measurements.
All assessments were performed before and after the inter-
vention by a physiotherapist who was unaware of alloca-
tion of the volunteers.
The ICIQ-OAB is a brief questionnaire specific to assess
OAB symptoms. It comprises 4 questions that measure the
impact of symptoms, such as urinary incontinence, urgency,
nocturia and daytime micturition frequency, on patients’
lives (11). The score of the questionnaire varies from 0 to 16,
and the higher the score, the greater the impact.
The ICIQ-SF is another brief questionnaire that assesses
the level and impact of urinary incontinence on patients’
lives. The ICIQ-SF is comprised of 3 questions that assess
daytime micturition frequency, the severity of urinary incon-
tinence and the impact of urinary incontinence on quality of
life. Furthermore, there are eight questions that assess the
possible causes of urinary incontinence. The final score is the
sum of the score from three first questions and varies from 0 to
21; the higher the score, the worse the outcome (12).
The 3-day bladder diary accounted for measuring the
frequency of urination, nocturia, urgency and urge incon-
tinence during 3 consecutive days. The mean frequency of
each symptom over the three days was considered the final
result (13).
Intervention
Using biphasic current and surface electrodes, both groups
underwent 8 sessions of 30 minutes of electrical stimulation
twice a week using a DUALPEX 961s (Quark, Brazil)
electrical stimulation device.
In G1, one surface electrode was applied below the left
medial malleolus, and the other electrode was applied 5 cm
cephalad to the distal electrode. To confirm the proper
electrode position, a frequency of 1 Hz and a pulse width of
200 ms were used, so the presence of rhythmic flexions of the
toes during the increase in stimulus intensity was indicative
of correct electrode placement. After this procedure, the
frequency was increased to 10 Hz, a therapeutic frequency
used to treat OAB symptoms (14). The intensity that was
used was just below that of the motor response.
For G2, the electrodes were positioned symmetrically in
the parasacral region under the posterior superior iliac spines
to stimulate nerve roots S2 and S3. A frequency of 10 Hz and
a pulse width of 700 ms were used (10). The level of intensity
was adjusted according to the patient’s tolerance.
Statistical analysis
Sample size calculation was based on a pilot study with 10
patients in each group, considering the scores of the first
outcome assessment, ICIQ-OAB, and the secondary outcome
assessment, ICIQ-SF. The program used for calculation was
the a priori method in the G*Power software (version 3.1.3;
University of Trier, Trier, Germany). Thus, a sample size of
17 and 23 participants, respectively, for G1 and G2 was
determined to have a power of 80% and an alpha error of 0.05.
Statistical analysis was performed using the Statistical Package
for Social Sciences (SPSS), version 22.0. A third researcher who
was blind to the groups’ alignment performed the statistical
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analysis that followed the principles of per-protocol (PP)
analysis. As the data lacked a normal distribution using the
Kolmogorov-Smirnov test, continuous data were presented
as the median and interquartile range. To compare results
within groups, the Wilcoxon test was used, and to compare
outcome results between groups, the Mann-Whitney test was
used. A p-value of 0.05 was considered significant.
’ RESULTS
According to the eligibility criteria, 58 patients were recrui-
ted, of whom 8 patients, four in each group, were excluded
because they could not attend the physiotherapy sessions.
Therefore, 25 patients per group completed the study
(Figure 1).
Demographic and initial assessments are shown in Table 1.
As no significant differences were found between groups,
assessments were homogeneous at baseline. Median and 25th
and 75th interquartile values of demographic and ICIQ-OAB
and ICIQ-SF scores and 3-day bladder diary data.
At the end of the treatment, both groups showed sig-
nificant improvements in the signs and symptoms of OAB,
but G1 showed a significant decrease in the number of
urgency episodes and urge urinary incontinence episodes,
Figure 1 - Flowchart.
Table 1 - Demonstration of demographic and clinical data (n=50).
Variable G1 G2 p-value
Age (years) 66 (65-73) 66.5 (62.5-75.75) 0.892
Parity (number) 4 (3-6) 4 (3-7.5) 0.577
Vaginal deliveries 2 (1-4) 3 (1.25-5.75) 0.337
ICIQ-OAB score 8.0 (6.7-11.2) 8.0 (6-12) 0.625
ICIQ-SF score 16.5 (15.5-18) 16.0 (13-18) 0.302
3-day bladder diary
Daytime micturition frequency 7.3 (4.1-10) 6.9 (5.5-10.0) 0.481
Nocturia 1.8 (0-1.6) 1.6 (1.2-3.3) 0.877
Number of urgency episodes 1.3 (0-1.6) 1.1 (0-3) 0.814
Number of urge urinary incontinence episodes 1.4 (0-2.5) 1.6 (0.2-3) 0.798
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whereas G2 did not show any differences in these assess-
ments. Although more significant findings were found in G1,
the improvements shown in the analysis within groups were
not enough to show differences between groups. The p-
values, medians and interquartile ranges of all assessments
after the treatment are described in Table 2.
Results of primary and secondary assessments after 8 weeks
of treatment. Median (SD) and 25th and 75th interquartile
ranges of demographic data, ICIQ-OAB and ICIQ-SF scores
and 3-day bladder diary data. There were no differences
between the groups. Both groups showed improvement in
questionnaire scores. G1 showed a significant decrease in
the number of urgency episodes, nocturia and urge urinary
incontinence, whereas G2 showed improvement only in the
reduction of nocturia episodes.
No side effects were noticed with either the tibial or
parasacral therapies.
’ DISCUSSION
The present study showed that both of the proposed
treatments were effective in the treatment of OAB, whereas
the tibial stimulation group showed more significant results
than the parasacral stimulation group. Electrode sites for
delivering electrical stimulation have different mechanisms
of action, but the goal for the final result is the same: to
achieve balance in the neural impulses that control the
bladder. The advantages and disadvantages of alternative
sites of electrostimulation in the treatment of OAB must be
tested to offer treatment options to the patients, and to our
knowledge, this is the first study that tested the treatment of
OAB using parasacral electrostimulation in adults (15).
Although both electrostimulation modalities showed the
same results in the majority of the variables at the end of the
treatment, the transcutaneous tibial nerve stimulation group
showed significant differences in the reduction of urgency
and urge urinary incontinence, whereas the parasacral group
did not show differences in these variables. Considering
that bladder innervations were modulated by the two sites
of electrostimulation, we suggest that the reasons for the
difference in these results are probably because, when
stimulating the tibial nerve, the correct position of the
electrodes can be confirmed by the presence of rhythmic
flexions of the toes during the increase in the stimulation
intensity. On the other hand, the positions of the electrodes
for parasacral stimulation are guided by anatomy, and there
is no way to confirm whether the nerve roots S2 and S3 are
adequately being stimulated; nevertheless, our results show
that parasacral stimulation is an alternative route when tibial
nerve stimulation is not possible (for example, in the case of
leg amputation or peripheral neuropathy).
The findings of this study corroborate those of a previous
retrospective study in which 24 elderly patients, with a mean
age of 70.25±11.14 years, received 30 minutes of percuta-
neous tibial nerve stimulation once a week for 12 weeks and
showed a reduction of urgency episodes, urge urinary
incontinence and nocturia (16). In a previous retrospective
study, 62 women with OAB, with a mean age of 72.7 years,
underwent 12 sessions of percutaneous tibial nerve stimula-
tion and presented a decrease in urgency and urge urinary
incontinence episodes (17); therefore, the electrical stimula-
tion of the tibial nerve seems to be effective in the treatment
of OAB in adults and elderly people. Even so, studies should
take into account the differences in idiopathic OAB in Ta
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different age groups as non-elderly people have no plausible
reason to develop OAB, and elderly people are likely to
have OAB because of anatomic changes caused by age.
Aging produces changes in the brain that can induce greater
sensation of the urgency to void, and older people can also
present bladder ischemia, which can lead to detrusor over-
activity or changes in bladder contractility. Another cause
of detrusor overactivity in elderly individuals compared to
the younger population is the increase in the non-neuronal
release of adenosine triphosphate and acetylcholine induced
by detrusor muscle stretch. Finally, elderly people have an
increased release of inflammatory mediators from the urothe-
lium that can initiate detrusor contractions without changes in
neurological control. Furthermore, postmenopausal women
have estrogen deprivation, as receptors of this hormone
are present in pelvic floor muscles, the bladder urothelium
and urethral epithelium, and its deprivation leads to an
impairment of bladder functioning (5). Future studies should
take age range into account, and further studies are needed
to determine which treatment model would achieve better
results in the treatment of elderly people.
The limitation of this study is the 8 sessions of treatment,
since studies usually treat OAB volunteers for 12 weeks (18).
Even so, the information that patients can benefit from a
reduced number of sessions is important in terms of the costs
of treatment. Furthermore, this study was also limited by the
lack of follow-up assessments, making it difficult to draw a
conclusion about how long treatment effects will last.
’ CONCLUSION
Although there were no differences between groups at the
end of the treatment in any assessment, TTNS and parasacral
electrostimulation were effective in reducing ICIQ-OAB
and ICIQ-SF scores; the TTNS group showed a significant
decrease in number of urgency episodes, nocturia and urge
urinary incontinence; and parasacral showed improvement
only in the reduction of nocturia episodes.
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